# EDGAR Filing Document

**Accession Number:** 0001000228
**File Stem:** 0001000228-26-000013
**Filing Date:** 2026-2
**Character Count:** 99968
**Document Hash:** 7e9490c698388495dd5d7a8218267baa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001000228-26-000013.hdr.sgml**: 20260224

**ACCESSION NUMBER**: 0001000228-26-000013

**CONFORMED SUBMISSION TYPE**: 10-K

**PUBLIC DOCUMENT COUNT**: 160

**CONFORMED PERIOD OF REPORT**: 20251227

**FILED AS OF DATE**: 20260224

**DATE AS OF CHANGE**: 20260224

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HENRY SCHEIN INC
- **CENTRAL INDEX KEY:** 0001000228
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES [5047]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 113136595
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1227

**FILING VALUES:**
- **FORM TYPE:** 10-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-27078
- **FILM NUMBER:** 26672433

**BUSINESS ADDRESS:**
- **STREET 1:** 135 DURYEA RD
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747
- **BUSINESS PHONE:** 6318435500

**MAIL ADDRESS:**
- **STREET 1:** 135 DURYEA RD
- **CITY:** MELVILLE
- **STATE:** NY
- **ZIP:** 11747

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SCHEIN HENRY INC
- **DATE OF NAME CHANGE:** 19950907

## Exhibit 10.45

**Exhibit 10.45** 

[date]

[name]

[address]

Dear [name]:

On behalf of Henry Schein, Inc. (the "Company"), this letter will serve to confirm our offer to you of the position of [title], reporting to [name], the Company's [title].

Below I have outlined the compensation and benefit components of our offer:

1. Base salary of $[xx] per annum, payable on a bi-weekly basis. You will
be eligible for your first salary review as of the end of March 20[xx].

2. For the balance of 20[xx], you will be eligible for an annual target bonus of up to [xx]% based on your
achievement of agreed upon goals and objectives established with [name]. [For 20[xx], we will guarantee $[xx] of the bonus which will be pro-rated based upon your start date. This bonus is payable in March
20[xx]. Thereafter, ] [y]our goals, objectives and performance bonus targets will be developed on an annual, ongoing basis.

3. You will also be eligible to participate immediately in the Company's 401(k) Retirement Plan and other
benefit programs including medical, dental, vision, life insurance, disability and other plans. A Benefits Program Summary is enclosed for your review.

4. [You will be eligible for the Company's relocation package (guidelines attached), which relocation should
be undertaken within a reasonable time period after commencement of your employment with the Company. The relocation must be coordinated through the Company's authorized outside relocation assistance firm. All reimbursable costs and/or items
for direct payment must be substantiated by actual receipts or other similar documentation.]

5. [So long as you are actively employed with the Company, within [xx] of your start date, you will receive a
Sign-On Bonus of $[xx], less appropriate tax withholdings.] [You will be entitled to a Sign-On Bonus of $[xx], less appropriate tax withholding once you complete [xx] of service.] If you leave the Company
within [xx] months of your start date, you will reimburse the Company for the entire Sign-On amount.

6. You will also be eligible to participate in Henry Schein's Long Term Incentive (LTl) program. The LTl
program currently consists of awards of [type of equity award(s)]. Your first award, which will be made following [date], will have a grant-date expected value of at least $[xx], provided in equal dollar amounts of [type of equity award(s)]. The
actual number of [type of equity award(s)] will be determined on the grant date. The grant date is [xx]. In the future, you will be eligible to participate in the Company's LTl program, or any successor equity award program offered by the
Company.

7. By your execution of this letter agreement in the space provided, and in consideration of your employment with
the Company and the compensation and benefit elements comprising such employment offer as set forth above, you acknowledge, covenant, understand and agree as follows:

a. The Company's policy of employment prohibits you from taking any confidential or proprietary information
with you from your current or any former employer, and you acknowledge that you have not done so and that the Company has actively discouraged you from doing so.

------

b. The Company's policy of employment prohibits you from using any such confidential information to the
detriment of any former employer in anticipation of, or when you are actually in, the employ of the Company, and, accordingly, you may not use any proprietary or confidential documents or information from any prior employer while employed by the
Company.

c. You represent that to the best of your knowledge, you do not have any written or oral employment or other
agreements with any previous employer or other entity which would prevent you from (i) fully and openly being employed by the Company, or (ii) giving your full time and best efforts to such employment, or (iii) actively and
aggressively pursuing your duties and responsibilities on behalf of the Company.

d. If at any time or for any reason, after joining the Company, you should leave its employ, then for a period of
12 months thereafter, you will not solicit, interfere with or endeavor to cause (i) any employee of the Company to leave his or her employment with the Company, or (ii) any customer or client of the Company to cease doing business with the
Company or to do business with any business enterprise or entity which provides products or services that are competitive with those provided by the Company.

e. During your employment with the Company and for a period of 12 months after your departure from the Company,
whether by resignation or termination for "cause" (as used herein, "cause" is defined as being terminated for (i) committing an act of fraud, dishonesty, embezzlement or misappropriation, or (ii) committing a crime
involving an act of moral turpitude, or (iii) materially failing to perform your duties as an employee of the Company), you will not, directly or indirectly, individually or as an employee, agent, owner, partner, joint venturer, shareholder of
more than two (2%) percent of stock, officer or director, whether for financial remuneration or not, engage or act in or on behalf of any business or entity which provides products or services that are competitive with those provided by the Company.

It is important to understand that our Company does not offer employment on a fixed term or guaranteed basis and the representations in this letter and those discussed in our meetings and phone conversations with you should not be construed in any manner as a proposed contract for any fixed term of employment. In addition, please note that the Company has a policy, when, as and if the Company deems it appropriate, of: a) verifying compensation representations made to it by offerees by requesting substantiating documentation of an offeree's recent total annual compensation; b) validating academic and professional credentials; and c) validating prior work experience. Finally, you should know that our employment application process entails drug screening and criminal background investigation elements, as well as reference checks with business and professional associates of yours, and this offer of employment is contingent on the Company's obtaining satisfactory reports with respect thereto.

Please contact me at your earliest convenience when you are in a position to respond to our offer and to discuss an expected start date. If you have any questions or desire further information, feel free to contact me at [xx].

Please acknowledge your acceptance of this offer by signing a copy of this letter and returning it to me.

We look forward to having you join Team Schein.

------

---

| |
|:---|
| Henry Schein, Inc. |
| By: |
| Name: |
| Title: |

---

---

| |
|:---|
| Accepted by:<br>|
| Date |

---

## Exhibit 10.46

**Exhibit 10.46**![LOGO](g36884g0217202029655.jpg)

August 23, 2023

Dear Andrea:

On behalf of Henry Schein, Inc. (the "Company"), this letter will serve to confirm our offer to you of the position of CEO, International Distribution Group, Global Dental Equipment and Lab based out of our Melville, New York headquarters, and reporting to Stanley Bergman, Chairman and Chief Executive Officer, Henry Schein, Inc., effective September 1, 2023 ("Transition Date").

Below I have outlined the compensation and benefit components of our offer:

**Base Salary: $575,000** per annum, payable on a bi-weekly basis. Salary reviews for exempt professional employees are generally conducted annually in March of each year. You will be considered for a salary review in March 2024. You recognize that the Company retains the right to establish and modify compensation, benefits and working conditions for its employees, and for its various categories of employees, in its sole discretion.

**Annual Bonus:** You will be eligible for an annual target bonus of **$402,500** based on your achievement of agreed upon goals and objectives established within 60 days of your Transition Date. Your goals, objectives and performance bonus targets will be developed on an annual, ongoing basis. In order to earn any annual bonus, you must be continuously employed from the date hereof through the date such bonus is paid, except as expressly provided below in the event the Company terminates your employment without cause (as defined below) prior to the fifth year anniversary of the Transition Date, or you and the Company cannot agree on a new position as set forth in the section entitled "Reassignment" below.

**Total Annual Cash: $977,500** 

**Annual LTIP:** You will also be eligible to participate in the Company's Annual Long Term Incentive (LTI) program. Your 2024 grant will have an estimated value of **$900,000** and is expected to be granted in March 2024, subject to your continued employment from the date hereof until the date of grant. The LTI program currently consists of equity issuable in accordance with the Company's 2023 Stock Incentive Plan. Future eligibility to participate in the Company's LTI program, or any successor equity award program offered by the Company, is subject to the sole and absolute discretion of the Compensation Committee. The actual equity award, if any, will be determined on the grant date. All awards shall be subject to the terms and conditions of the LTI program and the agreements incident thereto and the discretion and approval of the Compensation Committee.

**Total Annual Compensation (cash & equity): $1,877,500** 

**Sign-On Equity Award:** Your award, which will be made following the next quarterly Compensation Committee meeting following your Transition Date (subject to your continued employment from the date hereof through such grant date), will have a grant-date expected value of at least **$750,000.** The LTI program currently consists of equity issuable in accordance with the Company's 2023 Stock Incentive Plan. Future eligibility to participate in the Company's LTI program, or any successor equity award program offered by the Company, is subject to the sole and absolute discretion of the Compensation Committee. The actual equity award, if any, will be determined on the grant date. All awards shall be subject to the terms and conditions of the LTI program and the agreements incident thereto and the discretion and approval of the Compensation Committee. The grant date will be the second Friday of the last month of the Company's fiscal quarter end; provided, however, if the Compensation Committee approves a grant after the second Friday of the last month of a fiscal quarter but prior to such fiscal quarter end, then such grant shall have a grant date of the second Friday of the last month of the following fiscal quarter.

------

**Relocation Bonus:** You will receive a cash Relocation Bonus in the total amount of $1,500,000 payable in equal monthly installments of $31,250 over forty-eight (48) months beginning in September 2023, subject to your continued employment from the date hereof through each applicable payment date.

**Other Relocation Expenses:** You will be eligible to receive reimbursement for other relocation expenses as set forth in the accompanying Global Mobility Letter, dated August 23, 2023, and Relocation Policy, inclusive of any tax gross up consistent with Company practice (guidelines attached).

**Reassignment:** You may request a reassignment back to Europe after the second anniversary of the Transition Date and before the five (5) year anniversary of the Transition Date. The Company will try to accommodate your request at a compensation level commensurate for the new position. If the parties cannot reasonably agree on a new position in Europe within 6 months after your request, you will receive severance following your termination as set forth in "Termination" section below.

**Termination:** You acknowledge and agree that you are an employee at-will and that the Company may terminate your employment at any time, with or without Cause (as defined below). Upon termination by the Company for any reason, the Company shall have no obligation to you for any form of compensation or benefits, except as otherwise required by law or as expressly set forth in this paragraph, other than (a) unpaid salary earned or accrued through the date of termination, and (b) reimbursement of appropriately documented expenses incurred by you before the termination, to the extent that you would have been entitled to such reimbursement under the Company's policies but for the termination of employment.

In the event that the Company terminates your employment without Cause (as defined below) either: (a) solely prior to the 5 year anniversary of the Transition Date, if you and the Company cannot agree on a new position as set forth in the section entitled "Reassignment" above; or (b) on or after the 5 year anniversary of the Transition Date you shall receive as severance, subject to the conditions provided herein: (1) continued base salary for eighteen months (the "Severance Period") following the effective date of such termination, which shall be payable, subject to the following paragraph concerning Section 409A Compliance, in equal installments in accordance with the Company's payroll practices beginning on the first payroll date after the 60<sup>th</sup> day following your termination; (2) provided that you continue to live in the United States and make a timely election under COBRA, waiver of the applicable premium otherwise payable for COBRA continuation coverage for you (and, to the extent covered immediately prior to the date of your termination, your spouse and eligible dependents) for a period equal to the Severance Period (but in no event longer than the maximum COBRA period under applicable law) or if the Company determines that the waiving of the COBRA premiums would result in a violation of the Affordable Care Act, the nondiscrimination rules of Section 105(h)(2) of the Code or any other statute or regulation, then, in lieu thereof, you will receive monthly payments equal to the monthly "applicable premium," as that term is defined under COBRA; and (3) your annual bonus target amount, payable subject to the following paragraph concerning Section 409A Compliance, at the time the Company pays annual bonuses to its active employees. All amounts provided for in this paragraph are only payable provided that you timely execute (and do not revoke) a general waiver and release agreement agreed to by you in a form provided and approved by the Company. These severance payments will be subject to all regular and customary payroll deductions. You understand that in the event the Company reemploys you during the period which the severance benefits are being paid, severance payments will cease after you have received severance pay for all the weeks you were not employed by the Company. You also understand in the event that you breach any other agreement with the Company, including any non-competition or other restrictive covenant agreement with the Company, all severance payments will cease and the Company shall have the right to recover any severance payments previously paid to you.

In the event that your employment is terminated by the Company without Cause (as defined below) solely prior to the 5 year anniversary of the Transition Date, the Company also will apply special pro-rata vesting consistent with the Company's Rule of 70 guidelines with respect to any of your outstanding equity awards, subject to the terms and conditions of the Company's applicable standard form agreement.

------

Notwithstanding anything herein to the contrary, if you seek employment with or retention by any other company on or after the 5 year anniversary of the Transition Date, you shall inform the Company of your intention and, if applicable, shall seek permission from the Company to waive the restrictions of your Non-Compete, Non-Solicitation, Confidentiality and Inventions Agreement. Nothing herein shall be construed to require the Company to waive any such restrictions. If permission is granted or you accept employment with or retention by any other company, the Company will continue to provide you with the payments and benefits described in the second paragraph above under the heading "Termination", except that the severance as set forth therein shall be calculated as follows: the base salary severance payments shall be reduced by the weekly amount paid to you by your new company.

For purposes of this letter agreement, "Cause" shall mean your: (1) fraud, intentional and substantial misrepresentation or similar malfeasance, committed in connection with the performance of your duties hereunder; (2) theft of Company and/or one of the Company's affiliates property; (3) conviction of a felony or a crime involving moral turpitude whether or not related to your employment or entering a plea of guilty or nolo contendere (or similar plea) to a charge of such an offense; (4) use of alcohol to an extent that it interferes with the performance of your duties under this letter agreement or any unlawful controlled substance; (5) material violation of any express, lawful written direction of the Executive Committee of the Company or your manager or material violation of any written rule, regulation, policy or plan established by the Company and/or one of the Company's affiliates from time to time that is directly brought to your attention and about which you are given a warning regarding the conduct of its employees and/or its business and which material violation you failed to address or cure within a reasonable time; (6) gross insubordination; (7) repeated or continued absence (amounting to five full business days consecutively) from work during normal business hours for reasons other than disability, sickness, approved vacation or other approved time off; (8) written misrepresentation of a material fact or omission of information necessary to make the information supplied not materially misleading in any application or other information provided by you to the Company or any representative of the Company in connection with your employment with the Company and/or selection for the position contemplated hereby; (9) the unauthorized and intentional disclosure of Confidential Information (as defined in the accompanying confidentiality, non-solicitation, non-compete and/or inventions agreement); or (10) the existence of any knowing material conflict between the interests of the Company, including any of the Company's affiliates, and you that is not disclosed in writing by you to the Executive Committee of the Company within a reasonable time of the discovery of such conflict and approved in writing by the authority of the Executive Committee of the Company; provided, however, that "Cause" shall not be deemed to have occurred unless you have first received written notice of conduct complained of by the Company which specifically sets forth the conduct complained of and refers to this paragraph, and if such conduct is capable of being cured, you have failed to cure such conduct within a period of 30 days from the date of such notice.

**Section 409A Compliance:** Although the Company does not guarantee you any particular treatment related to the payments hereunder, it is intended that the payments and benefits herein shall be exempt from, or comply with, Section 409A of the Internal Revenue Code and the regulations and guidance promulgated thereunder (collectively "Section 409A"), and all provisions of the Agreement shall be construed in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A. Notwithstanding anything herein to the contrary, in no event whatsoever shall the Company be liable for any taxes or penalties that may be imposed on you by Section 409A or any damages for failing to comply with Section 409A. Notwithstanding anything contained herein to the contrary, to the extent applicable, each and every payment made hereunder shall be treated as a separate and distinct payment and not as a series of payments. In no event shall you designate the tax year of the commencement of any payments or benefits hereunder and the Company shall determine the actual commencement date of payment of any payments or benefits hereunder. Notwithstanding the foregoing or anything else contained herein to the contrary, if you are a "specified employee" (determined in accordance with Section 409A), and if any payment or benefit provided for herein constitutes a "deferral of compensation" under Section 409A, then any such payment or benefit that is payable during the first 6 months following the date of separation from service shall be paid or provided to you in a lump sum cash payment to be made on the earlier of (x) your death (solely to the extent that any payment is required to be made following death), or (y) the first payroll date of the seventh calendar month immediately following the month in which the separation from service occurs. A termination of employment shall not be deemed to have occurred for purposes of any provision of this letter providing for the payment of any amounts or benefits that are subject to Section 409A, upon or following a termination of employment unless such termination is also a "separation from service" within the meaning of Section 409A and, for purposes of any such provision in this letter, references to a "resignation," "termination," "termination of employment," or like terms shall mean separation from service. To the extent that any reimbursements payable pursuant to this letter agreement are subject to the provisions of Section 409A, (i) any such reimbursements payable to you pursuant to this letter agreement shall be paid to you no later than December 31<sup>st</sup> of the year following the year in which the expense was incurred, (ii) the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, and (iii) your right to reimbursement under this letter agreement will not be subject to liquidation or exchange for another benefit.

------

**Directors and Officers Liability Insurance:** You will be covered under the Company's directors and officers liability insurance policies as set forth in the applicable policy documents.

**401(k) Retirement Plan:** You will also be eligible to participate immediately in the Company's 401(k) Retirement Plan and other benefit programs including medical, dental, vision, life insurance, disability and other plans, subject to their terms and conditions. The 401(k) Savings Plan allows you to save money for retirement on a pretax basis and provides an annual matching contribution of up to 7% of your base pay. Please note that the 401(k) Savings Plan has an automatic enrollment feature, meaning that you will be automatically enrolled at a contribution rate of 3% if you do not opt out of the plan within 60 days of your hire date.

**Supplemental Executive Retirement Plan (SERP):** You will be eligible to participate in the Company's Supplemental Executive Retirement Plan (SERP), subject to its terms and conditions, beginning in 2024. Under the current plan, the Company makes a contribution into the SERP equal to the amount by which your Base Compensation exceeds "Recognized Compensation" (currently $321,428 for 2023 which is subject to change by the IRS) multiplied by seven percent (7%).

**Paid Time Off:** You will be entitled to thirty (30) PTO days in your first year and subsequent year(s) of employment in accordance with the Company's paid time off policy for other similarly situated employees of the Company, subject to the Company's generally applicable policies related to PTO.

**Clawback:** You expressly agree and acknowledge that your cash and non-cash incentive compensation (whether provided under this letter or otherwise) shall be subject to the terms and conditions of the Company's Incentive Compensation Recoupment Policy approved by the Company's Board of Directors in March 2016 or any other clawback policy adopted by the Company.

**Entire Agreement:** This letter represents the entire agreement of the parties and shall supersede any and all previous contracts, arrangements or understandings between and among you, the Company and its affiliates, with respect to the subject matter, including, without limitation, the employment agreement between Henry Schein Krugg s.r.l. and you, dated October 9, 2013, as amended by the addendum, dated October 22, 2021.

It is important to understand that you will be employed "at-will," that our Company does not offer employment on a fixed term or guaranteed basis and the representations in this letter and those discussed in our meetings and phone conversations with you should not be construed in any manner as a proposed contract for any fixed term of employment.

You will be required to execute a Non-Compete, Non-Solicitation, Confidentiality and Inventions agreement as a condition of your employment. This offer and your employment with the Company are contingent on your execution of this document as requested by the Company.

Please contact me at your earliest convenience when you are in a position to respond to our offer and to discuss an expected start date. If you have any questions or desire further information, feel free to contact me at ***[\*\*\* - personal information]***.

Please acknowledge your acceptance of this offer by signing a copy of this letter and returning it to me.

I look forward to having you join Team Schein in New York.

------

---

| |
|:---|
| Very truly yours, |
| /s/ Lorelei McGlynn |
| Lorelei McGlynn<br> SVP & Chief Human Resources Officer |
| Lorelei McGlynn<br> SVP & Chief Human Resources Officer |

---

---

| |
|:---|
| /s/ Andrea Albertini |
| Andrea Albertini |

---

## Exhibit 10.47

![LOGO](g36884g47x71.jpg)

------

![LOGO](g36884dsp196a.jpg)

August 23, 2023

Dear Andrea Albertini:

Congratulations on your upcoming international move. As part of the continuing development of your career at Henry Schein, we are pleased to share with you the details of your move. This letter confirms our mutual understanding of the terms and conditions applying to your move. The letter is neither intended, nor to be construed, as an employment contract of any type or as an undertaking by Henry Schein Inc, (the "Company") and any of its subsidiaries. Your employment during the move, and the terms of this outline, are subject to the Company's personnel policies, compensation programs and benefit plans. The Company reserves the right to modify the terms and conditions of your move due to changes in applicable Company policy.

**Home City and Country: Bologna, Italy** 

**Host City and Country: New York, U.S.A.** 

**Move Title: CEO, International Distribution Group, Global Dental Equipment and Lab** 

**Estimated Move Effective Date: September 1, 2023** 

All move terms and conditions that apply to you are summarized in the Henry Schein Global Mobility Policy for a Local Permanent move. You are responsible to review and agree to both this letter and the policy document.

Your move is conditional upon the issue and maintenance of valid residency, work and/or any other permits necessary to legally reside and work in your host location as well as your acceptance of the terms and conditions outlined in this letter and in the policy detailed above. The move will be effective only after the Move Letter has been signed by both parties and other condition(s) of move have been met.

**COMPENSATION AND BENEFITS** 

You will be placed on host country compensation and incentive target and will participate in the host country health care and retirement plans upon relocation. Additional benefits specific to your home/host location may apply and will be outlined in the attached provision summary. Your original hire date will be maintained and you will follow host country policies for vacation entitlement, work schedule and holidays.

Please refer to the Move Allowance Summary for specific details of your compensation and move related allowances and services.

Local Permanent Move Letter

------

![LOGO](g36884dsp196a.jpg)

**TSM EXPECTATIONS** 

During the course of your move, you may not engage in any employment or business enterprise that will in any way conflict with your service to, or the interests of, the Company. You will be required to comply with all applicable laws in the host country.

**TAX POLICY & ASSISTANCE** 

You will be responsible for complying with any and all applicable income tax regulations in your home and host country and in any other countries where you are required to pay taxes. The Company will provide tax filing assistance through a designated tax services provider.

You will be responsible for all actual taxes (in all jurisdictions as applicable) on base compensation which includes the base salary, bonus and long-term incentives. For other move-related support elements that enable the relocation to the Host Country, along with elements to aid you during the move period, to the extent these move-related elements are taxable; Henry Schein will be responsible for the tax due on these items. Below is a list of the potential items for which you may be eligible to receive and which income and/or social taxes may be due that will be the responsibility of Henry Schein:

• Any taxable items you receive prior to the move (defined as the Pre-Move phase)

• Move-related support elements you receive during and after the move (defined as the Post-Move phase)

In some cases, the effect of the move on your tax obligations will last longer than the year of the move. For this reason, the tax filing assistance will be provided for

• The year of the move from the Home Location to the Host Location

• Four (4) years after the move or until residual tax expenses are complete

**ACCEPTANCE** 

You recognize that the Company retains the right to establish and modify compensation, benefits and working conditions for its TSMs, and for its various categories of TSMs, in its sole discretion. It is important to understand that our Company does not offer employment on a fixed term or guaranteed basis and the representations in this should not be constructed in any manner as a proposed contract for any fixed term of employment.

Local Permanent Move Letter

------

![LOGO](g36884dsp196a.jpg)

I have read and fully understand and accept the terms and conditions of the move as outlined in this letter.

---

| | | |
|:---|:---|:---|
| TSM: | /s/ Andrea Albertini | Date: August 23, 2023 |
|  | Andrea Albertini |  |
| Authorized Signer: | /s/ Lorelei McGlynn | Date: August 23, 2023 |
|  | Lorelei McGlynn |  |

---

Local Permanent Move Letter

------

![LOGO](g36884dsp196a.jpg)

Assignment Allowance Summary

TSM Name: Andrea Albertini

Family Size: Three (3): Self, Spouse, Son

Assignment Type: Local Permanent

Estimated Assignment Effective Date: September 1, 2023

---

| | | | |
|:---|:---|:---|:---|
| TSM Base Compensation | Amount and Currency | Pay Frequency | Gross/Net |
| Annual Base Salary & Currency (*includes Car Allowance*): | $575,000 USD | Annual | Gross |
| Variable Pay: | $402,500 USD | Annual | Gross |
| Equity | $900,000 USD | Annual – start March 2024 |  |
| One Time Equity | $750,000USD | One Time – Granted in September 2023 |  |
| Assignment Allowances | Amount and Currency | Payment Type | Gross/Net |
| <u>**Relocation Bonus Award:**</u> | $1500000 | Paid in equal monthly installments beginning September 2023 and continuing for 48 months. ($31,250/mo.) | Gross |
| **<u>Other One Time Items as listed below to be paid by the Company:</u>** | **Estimate - TBD:**<br> **$155,000 USD**<br> **Year (1)**<br> **$37,500 (Years 2,3 & 4)** | **Company Paid Directly to Vendors as follows:** |  |
| &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Immigration Visas for TSM/Family**<br>|  | Greenspoon Marder |  |
| &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Transportation of Goods – Air Shipment (500 lbs)**<br>|  | Continuum Relocation |  |
| &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Estimated employer US tax cost on relocation services**<br>|  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Furniture Allowance**<br>| $50000 | One-Time Payment to TSM | Gross |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• **Deloitte Tax Services:**<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Pre-Assignment Tax Estimates<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Exit Home & Enter Host Location Interview<br>| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>TBD – Estimate $1K for E/E and $2,500 per Return + cost of Italy Return | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>Directly to Deloitte |  |

---

Local Permanent Move Letter

------

![LOGO](g36884dsp196a.jpg)

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Deloitte Tax Preparation – **Four (4) years Tax Assistance or until residual tax expenses completed** (*Employees are responsible for paying all actual home/host country taxes without support from the Company*)<br>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Ongoing Periodic Tax Advice, as needed<br>|  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; • Destination/Cultural Services – 2 -3 days w/3<sup>rd</sup> Party Provider – home finding; familiarize with Country; Schools; Location Registration & paperwork; shopping; dining; medical facilities, etc.<br>| TBD | Paid Directly to Continuum/Relocation/Cooper & Cooper |
| &nbsp;&nbsp;&nbsp;&nbsp; • Home Leave – TSM will be eligible for three (3) home visits per year for a period of 4 years (TSM; Spouse; Dependent)<br>| TBD | Charge to Cost Center |

---

Local Permanent Move Letter

## Exhibit 10.48

**Exhibit 10.48**![LOGO](g36884g0217202909065.jpg)

**RESTRICTIVE COVENANT, CONFIDENTIALITY AND INVENTIONS AGREEMENT** 

This Restrictive Covenant, Confidentiality and Inventions Agreement ("Agreement") is made and entered into effective as of the 23 day of August, 2023, by and between Henry Schein, Inc., a Delaware corporation headquartered in New York ("the Company") and Andrea Albertini ("Employee").

**<u>RECITALS</u>**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A. WHEREAS, Employee is an executive of the Company, most recently working as CEO, International Distribution Group; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;B. WHEREAS, Employee is being promoted to the position of Chief Executive Officer, International Distribution Group and Global Dental Equipment and Lab, and, in this capacity, is expected to serve as CEO of the International Distribution Group, and to lead the Dental and Lab business verticals, including in achieving their digital equipment and laboratory product and service, strategic and profit targets; Employee is also expected to work to ensure strategic guidance and best practice sharing in the integration and success of the digital workflow platform as a fundamental part of the Company's strategies.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;C. WHEREAS, in the new capacity to which he is being promoted, Employee will be one of the most senior executives in the Company, leading and helping to lead, a key area, and a significant portion of the Company's business; Employee's position with the Company is a position of trust and confidence; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;D. WHEREAS, the parties acknowledge that Employee is and will be a unique employee of the Company, and that Employee will be privy to key and critical confidential information and trade secrets concerning the entire Company, its affiliates, and their businesses, planning, personnel, strategic initiatives, expansion and futures, and concerning the interaction among the businesses of the Company's various units, subsidiaries and affiliates, including businesses, segments and/or areas in which the Company has and/or is developing interests or expanding into; the parties further acknowledge that in connection with and/or as part of Employee's employment by the Company, Employee is expected to have access to, will have knowledge of, and will assist in developing, highly confidential and proprietary information related to the Company, its plans, affiliates, divisions, groups, personnel, and/or their businesses, products and services, including new and additional confidential and trade secret information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;E. WHEREAS, entry into this Agreement is a material part of Company agreeing to promote Employee; and

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;F. WHEREAS, Employee has had an opportunity to consider the matter, has had the opportunity to review the terms and restrictions hereof with independent legal counsel of his own choosing, and has made an independent and informed decision that this Agreement is (a) fair and not excessive; (b) necessary for the protection of the Company and its business; and (c) that entry into this Agreement, and compliance with the terms hereof, including the restrictions set forth herein, is reasonable and is something that he chooses to do.

NOW, in consideration of the premises, of $20,000, of the opportunity to earn enhanced compensation, and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:

**I. <u>COVENANTS AND OTHER TERMS</u>** 

**A.** **Definitions.** The following terms shall be defined as provided below for purposes of this Agreement.

1. <u>Separation Date.</u> The phrase "Separation Date" as used throughout this Agreement means the
effective date of Employee's termination from employment with the Company, whether by resignation or termination for any reason. In the event Employee's employment with the Company is terminated and Employee is subsequently rehired by
the Company in the same or any other position, the phrase "Separation Date" shall refer to the most recent date of Employee's termination from employment with the Company.

2. <u>Period of Restriction.</u> The phrase "Period of Restriction" as used throughout this Agreement
is defined to mean the period commencing on the date of this Agreement and continuing throughout Employee's employment with the Company and for a period of eighteen (18) months after the Separation Date.

3. <u>Restricted Area.</u> The parties recognize that Employee's responsibilities and work for the Company,
will be Global and is expected to extend to all of the geographic territories in which the Company does business. The phrase "Restricted Area" as used in this Agreement shall mean (i) the United States, and (ii) such additional
countries globally: (A) where Employee works or performs services on behalf of the Company at any time during the three years prior to the Separation Date; (B) where a business group of the Company or an affiliate, that reported to
Employee, or that Employee was involved in supervising or managing, at any time during the thirty six (36) months prior to the Separation Date, is engaged in business and/or is providing products, technology and/or services at any time during
the thirty six (36) months prior to the Separation Date; and/or (C) in or to which Employee's efforts on behalf of the Company were directed, at any time during the thirty six (36) months prior to the Separation Date;
(iii) in addition, during the period when Employee is employed by the Company or an affiliate, the Restricted Area shall also include the geographic territories in which the Company and such affiliate do business.

4. <u>Restricted Business</u>. The term "Restricted Business" shall mean and include: (A) any
business in which the Company's International Distribution Group (by whatever name it may then be known) engages, at any time during the three (3) years prior to the Separation Date, and/or in which, as of the Separation Date, the Company
is planning to engage at any

------

time within the year after the Separation Date; (B) any business in which the Company's Dental Equipment and Lab businesses (by whatever name they shall then be known) engage, at any time during the three (3) years prior to the Separation Date, and/or in which, as of the Separation Date, the Company is planning to engage at any time within the year after the Separation Date; (C) any business of the Company, its subsidiaries or affiliates, which Employee managed, or assisted in managing, or which reported to Employee, at any time during the three (3) years prior to the Separation Date; (D) the businesses of the Company, its subsidiaries or affiliates, about which Employee, at any time during the two (2) years prior to the Separation Date, learned, developed or utilized, Confidential Information; (E) a business in which Employee was materially involved in the Company's actual or attempted acquisition, at any time during the two (2) years prior to the Separation Date; and/or (F) a business which attempts to compete with, or is in the same line of business as, a business described in subsections (A) through (E), above. Notwithstanding the foregoing, and for purposes of clarity: (i) the parties agree that the definition of a "Restricted Business" will not prevent Employee from being retained or employed, after the Separation Date, by a non-competitive division, subsidiary or affiliate of an entity that is also engaged in a Restricted Business, or in a position with such entity that is not involved in competing with a Restricted Business, provided that Employee has no involvement, directly or indirectly, and does not assist with or contribute to, work or activity from which Employee is prohibited by this Agreement; (ii) Subsection (A), above shall not be applicable to Employee if he is not involved in the leadership, oversight or supervision of the International Distribution Group (by whatever name it shall then be known) at any time during the three (3) years prior to the Separation Date; (iii) Subsection (B), above shall not be applicable to Employee if he is not involved in the leadership, oversight or supervision of the Company's Dental Equipment and Lab businesses (by whatever name it or they shall then be known) at any time during the three (3) years prior to the Separation Date.

5. <u>Customer.</u> The term "Customer" as used throughout this Agreement shall mean any client,
account or customer of the Company, its subsidiaries and/or affiliates: (x) whom Employee solicited, sold to or serviced, on behalf of the Company or any of its businesses, subsidiaries or affiliates, at any time during the thirty six
(36) months preceding the Separation Date, and/or (y) on whose account Employee worked on behalf of the Company, or any of its businesses, subsidiaries or affiliates, at any time during the thirty-six (36) months preceding the Separation Date, and/or (z) concerning whose account, Employee, at any time during the thirty-six (36) months
preceding the Separation Date, reviewed, utilized, created or developed, Confidential Information.

6. <u>Vendor.</u> The term "Vendor" shall mean any vendor or supplier to the Company or any of its
subsidiaries or affiliates (other than a vendor of utilities or maintenance products or services, for the Company's own premises): (i) with whom, at any time during the thirty-six (36) months prior
to the Separation Date, Employee, or any of the Employees who reported directly to Employee at the time of contact ("Report" or "Reports"), had material contact on behalf of the Company; or (ii) for whom Employee was the
contact person on behalf of the Company at any time during the thirty-six (36) months prior to the Separation Date.

------

**B.** **Covenant Concerning Competitive Activity.** During the Period of Restriction, except while employed
by the Company, and acting on behalf of the Company, its subsidiaries and/or affiliates, Employee shall not, directly or through others: (i) engage, anywhere in the Restricted Area, in any Restricted Business, and/or aid others in, and/or work
in aid of, any Restricted Business; (ii) engage in, consult on, or assist, anywhere in the Restricted Area, in the business, management, development and/or acquisition of, any Restricted Business; (iii) contact, solicit, advise, provide
products, services, technology, software and/or equipment, to, or consult with, any Customer, for the purpose, or with the effect, of encouraging or causing the Customer to consider, purchase, license or otherwise obtain products, services,
technology, software and/or equipment from a person, firm, business or entity other than the Company or an affiliate, where such products, services, technology, software and/or equipment, or competing products, services, technology, software and/or
equipment, could have been acquired through the Company; (iv) be involved in the planning, promotion, marketing, distribution, servicing or sale, within the Restricted Area, of products, services, technology, software, businesses and/or
equipment, that compete with, attempt to compete with, or are in the same line of business as, any Restricted Business; (v) consult concerning, evaluate, and/or engage in, investment, merger and/or acquisition activity and/or transactions
involving the sale or acquisition of a business or line of business, where such business or line of business competes or attempt to compete with Restricted Business(es), or are in a line of business within the definition of Restricted Business as
set forth above; and/or (vi) without the prior written consent of the Company, pursue, engage in or utilize on behalf of anyone other than the Company or its affiliates, any proposed business arrangement or business plan on which Employee
worked while employed by the Company or an affiliate. Further, during the Period of Restriction, Employee shall not directly or through others, interfere with the business relationship between the Company, its subsidiaries, divisions and/or
affiliates, and any Customers or Vendors. The restrictions set forth in this paragraph: (x) shall restrict activity in the Restricted Area, and (y) shall also restrict actions and activity conducted from outside of the Restricted Area,
which are directed to the Restricted Area (such as phone calls, remote conferences or computer-based activity outside of the Restricted Area that communicate concerning, are in furtherance of, or contribute to, activity from which Employee is
prohibited within the Restricted Area).

**C.** **Covenant Concerning Non-Solicitation of Company Employees; Non-Interference.** During the Period of Restriction, Employee shall not, directly or through others, for or on behalf of anyone competing or attempting to compete with any aspect of the business of the Company,
recruit or aid in the recruiting of, or solicit for employment, any employee or consultant of the Company; further, Employee shall not, during the Period of Restriction, advise, identify or recommend to any person, firm, business or entity that is
competing or attempting to compete with any aspect of the business of the Company, that they employ or solicit for employment, any employee or consultant of the Company. The foregoing restrictions shall be limited to pertain to employees and/or
consultants of the Company, its subsidiaries and/or affiliates: (x) with whom Employee worked while at the Company, and/or (y) whom Employee supervised on behalf of the Company, its subsidiaries and/or affiliates, and/or (z) about
whose function, work and/or performance, Employee learned during Employee's employ with the Company.

------

**D.** **No Conflicting Obligations; Further Covenant.** Employee further covenants and agrees that, during the
Period of Restriction, Employee will comply with this Agreement, will not engage in activities that conflict with Employee's obligations hereunder, and will not interfere with, and will not aid anyone else in interfering with, the
relationships between the Company and its Customers and/or Vendors.

**E.** **Acknowledgment of Reasonableness of Restrictions.** Employee specifically acknowledges and agrees that the
nature of the limitations upon Employee's activities as specified herein, together with the duration and scope of such restrictions, are reasonable limitations on Employee's activities and that the restrictions are required to preserve,
promote and protect the trade secrets, Confidential Information, goodwill and other legitimate interests of the Company, and impose no greater restraint than is reasonably necessary to secure such protection. Employee represents and warrants that he
has carefully considered the provisions hereof, and that he is willing to agree hereto, and that he will enter into and comply with this Agreement. Employee further represents and warrants that the provisions of this Agreement will not substantially
impair Employee's ability to earn a livelihood, nor will such provisions cause Employee any undue hardship.

**F.** **Interpretation of Covenants.** In the event that any provision of this Agreement shall be held invalid or
unenforceable by a court of competent jurisdiction by reason of the duration or scope thereof or for any other reason, such invalidity or unenforceability shall attach only to the specific provision determined to be unenforceable, and the rest of
the covenants and the Agreement shall remain in full force and effect. Employee and the Company intend that the restrictions and provisions set forth in this Agreement shall be deemed to be severable, and shall further be deemed to be a series of
separate covenants. Further, to the greatest extent permitted by law, the parties agree that, in the event a court determines that a provision hereof is invalid or unenforceable, that the court, to the greatest extent permitted by law, modify such
provision in a manner permitted by law, to afford the greatest protection permitted by law consistent with the intent expressed in this Agreement, and, as so modified, that the court enforce the provision.

**G.** **Notification to Future Employers**. Employee agrees that no later than ten (10) days after accepting
employment, contracting with or agreeing to provide services to another person or entity during the Period of Restriction, Employee will so advise the Company, and the Company may, in its discretion, inform of the terms hereof, and/or provide a copy
of this Agreement, to the entity to which Employee is or will be employed or providing services. Employee hereby waives any claims against the Company or its representatives due to the Company's providing this Agreement to any such entity,
including but not limited to claims for defamation and/or interference with contractual relations.

**II. FURTHER PROTECTION OF CONFIDENTIAL AND** 

**PROPRIETARY INFORMATION** 

**A.** **Confidential and Proprietary Information.** The parties hereto agree and acknowledge that the following
information and materials in written, oral, electronic, magnetic, photographic or any other form, are the confidential and/or proprietary information of the Company ("Confidential Information"):

------

1. All nonpublic information, in any form, related to the current and/or prospective businesses and/or activities
of the Company, its subsidiaries, divisions and/or affiliates, which is utilized, developed or obtained by the Company, its subsidiaries, divisions and/or affiliates, and/or any of their employees, including but not limited to: research and
development activities; products; acquisitions and potential acquisitions being analyzed; strategic analysis; Technology; strategy; organization; finances; software; technical and/or product matters; nonpublic pricing, including, but not limited to,
proprietary pricing, and special pricing for individual customers, GPOs, IPNs and other organizations and buying groups; costing; nonpublic customer and supplier related information; nonpublic marketing and sales information; business opportunities,
potential and/or nonpublic acquisitions, joint-ventures, divestitures and reorganizations; credentials to Company accounts, including passwords to company websites and company-focused social media; organizational issues; legal matters; trade
secrets, other intellectual property information and nonpublic applications; algorithms; inventions; manufacturing, production and operations processes and plans; business plans; analyses, forecasts and methodologies; projections; operational
matters; digital analyses; internal reports and analyses concerning the Company's business or an aspect thereof; internal reports concerning customers, suppliers, products, sales and/or potential or pending transactions; and other materials
and information which the Company considers to be nonpublic, confidential or trade secret, and which are not excluded from this definition pursuant to paragraph 3 below.

2. Confidential Information shall also include a third party's information received by the Company subject
to an obligation or understanding of confidentiality, including, but not limited to, credit, financial and/or other information subject to confidentiality obligations under HIPAA.

3. Notwithstanding the foregoing, Confidential Information shall not include information which was generally known
by, or readily available through proper means to, the general public or the trade, prior to Employee's receipt, use or disclosure of it, but shall include the Company's internal analysis and/or further development of such information.
Notwithstanding any other provision of this Agreement, Employee may not disclose or utilize, and shall protect and keep confidential, any information that Employee released or releases to third parties or the public, in violation of Employee's
obligations by law or hereunder.

4. As used herein, "Technology" shall mean any and all ideas, concepts, inventions, discoveries,
developments, designs, derivatives, modifications, improvements, research information, works of authorship, methods, systems, processes, products, prototypes, apparatus, equipment, specifications, schematics, data, software (including, without
limitation, both source code and object code), hardware, communications and networking systems, content, drawings, files, databases, code, graphics, formulae, algorithms, techniques, technology and know-how, whether or not patentable or copyrightable; and all copies and tangible embodiments of any of the foregoing, and all related notes, reports, summaries, memoranda and other documentation, in each case, in whatever form or medium.

------

**B.** **Protection of Confidential and Proprietary Information.** Employee agrees to take at least the steps
described below to preserve the confidentiality of all Confidential Information. It is understood and agreed that Employee's obligations under this Section III of this Agreement, and in connection with the steps described below, shall, subject
to Section III (B) (4), below, survive and remain enforceable indefinitely, or as otherwise required or permitted by law, until the item of Confidential Information at issue, is no longer confidential or is otherwise no longer subject to protection
under the terms hereof.

1. <u>Nondisclosure.</u> Employee will not use, disclose or otherwise permit any person or entity access to any of
the Confidential Information other than as required by the Company for its benefit. Employee shall not, under any circumstances, disclose, or make use of, any Confidential Information for Employee's own purpose or benefit or for the benefit of
any person or entity other than the Company.

2. <u>No Copies</u>. Employee shall not make any copies, abstracts or summaries of any Confidential Information,
or any other Company-owned or controlled documents or information, or any duplicates of Company-owned or controlled electronic or other data storage media, which Employee may have in Employee's possession or control, other than as required for
the use and benefit of the Company.

3. <u>Prevent Disclosure.</u> Employee will take all reasonable precautions to prevent disclosure of any
Confidential Information to persons or entities other than the Company.

4. <u>Exceptions.</u> Notwithstanding the foregoing, Employee shall not have liability to the Company hereunder
with respect to use or disclosure of Confidential Information, provided that one of the following is established with respect to the information at issue: (a) the Confidential Information was disclosed or made public with prior written consent
of the Company; (b) the Confidential Information was received by Employee after his employment with the Company ended, without any restriction or confidentiality obligation, from a source other than the Company, which source was in lawful
possession of such Confidential Information, and was lawfully able to provide it without restriction or confidential obligation, and did provide it without any restriction or confidentiality obligation; or (c) Employee is compelled by a court
of law, or pursuant to government process, to disclose such information. Further, notwithstanding the foregoing, Employee acknowledges that nothing herein prevents Employee from filing a charge or complaint with, or voluntarily participating in an
investigation or proceeding conducted by, any government agency, self-regulatory body or law enforcement authority or from testifying truthfully in the course of any administrative, legal or arbitration proceeding.

**C.** **Return of Confidential Information.** Upon the request of the Company or, if no request is made, upon
termination of Employee's employment with the Company, Employee shall promptly return to the Company all Confidential Information and all originals and copies of all records, documents, drives, tapes, magnetic disks, notes, reports, proposals,
lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment and/or other media of any type or nature in Employee's possession or control containing Confidential Information. Employee shall not retain any copies
of, or access to, any Confidential Information. Employee shall not destroy Confidential Information in his possession, without the express authorization of the Company. Employee shall also disclose to Company all passwords and other information
required to access Company information and/or materials.

------

**D.** **Return of Company Property.** Upon the request of the Company or, if no request is made, upon termination
of Employee's employment with the Company, Employee shall promptly return to the Company all Company property in Employee's possession, including, but not limited to, Confidential Information, product samples, documents, manuals,
catalogs, mobile phones, tablets, electronic media, access to media and laptops. Employee shall not destroy Company Property in his possession, without the express authorization of the Company.

**E.** **Disclosure of Trade Secrets.** Nothing in this Agreement prohibits or restricts Employee from reporting an
event that Employee reasonably and in good faith believes is a violation of law to the relevant law-enforcement agency (such as, without limitation, the Securities and Exchange Commission, Equal Employment
Opportunity Commission, or Department of Labor), or from cooperating in an investigation conducted by such a government agency, or making disclosures to such an agency. Employee is hereby provided notice that under the 2016 Defend Trade Secrets Act
no individual will be held criminally or civilly liable under Federal or State trade secret law for the disclosure of a trade secret (as defined in the Economic Espionage Act) if the disclosure is: (i) made in confidence to a Federal, State, or
local government official, either directly or indirectly, or to an attorney, and made solely for the purpose of reporting or investigating a suspected violation of law; or (ii) made in a complaint or other document filed in a lawsuit or other
proceeding, if such filing is made under seal so that it is not made public. An individual who pursues a lawsuit for alleged retaliation by an employer for reporting a suspected violation of the law may disclose the trade secret to an attorney of
the individual and use the trade secret information in the court proceeding, if the individual files any document containing the trade secret under seal, and does not disclose the trade secret, except as permitted by law or court order. In order for
a disclosure to be permitted and protected under this provision, it must be made in strict accordance with limitations under law, as described above.

**III. <u>ASSIGNMENT OF INVENTIONS</u>** 

**A.** **Definitions.** The following terms shall be defined as provided below for purposes of Section III of this
Agreement.

1. "Work Product" shall mean all Technology and Confidential Information, as defined in Section II of
this Agreement, and other information which relate to known, proposed or reasonably anticipated business pursuits of the Company and/or its affiliates.

2. "Prior Work Product" shall mean all Work Product that was conceived in whole or in part by Employee
prior to Employee's employment with the Company to which Employee has any right, title or interest, and which relate to the Company's proposed business, products, or research and development.

------

3. "Company Work Product" shall mean Work Product that Employee may solely or jointly conceive of,
create, develop or reduce to practice, or cause to be conceived of, developed or reduced to practice within the scope of Employee's employment by the Company (whether or not during business hours) with the aid assistance or use of the
property, equipment, facilities, resources, Confidential Information, trade secrets or other intellectual property of the Company and/or its affiliates, or related to the current or anticipated business, research or development of the Company or its
affiliates.

4. "Intellectual Property Rights" means all intellectual property rights throughout the world,
including, without limitation, (i) all rights relating to the protection of inventions, including patents, patent applications and invention disclosures; (ii) all rights in works of authorship, copyrightable works, registered and
unregistered copyrights, all rights to databases and data collections, and registrations and applications for registration thereof; (iii) all rights in mask works and registrations and applications for registration thereof; (iv) all rights
in registered and unregistered trademarks, service marks, trade names, corporate names, logos, trade dress, designs, packaging, Internet domain names, and registrations and applications for registration thereof, together with all goodwill associated
therewith; (v) all rights relating to the protection of computer software (including, without limitation, both source code and object code); (vi) all rights relating to the ownership and/or protection of trade secrets, know-how and proprietary information; (vii) all moral and economic rights of authors and inventors, however denominated, throughout the world; (viii) all copies and tangible embodiments of any of the
foregoing in whatever form or medium; (ix) all rights to obtain renewals, reissues, reexaminations, continuations, continuations-in-part, divisions or other
extensions of legal protections pertaining thereto; (x) all claims or causes of action arising out of or related to any infringement or misappropriation of any of the foregoing; and (xi) any right analogous to those set forth in this
Section 4.

**B.** **Rights Retained by Employee.** Employee shall attach to this Agreement at the time of execution as
Appendix A, a list describing all Prior Work Product; or, if no such list is attached, Employee represents and warrants that there is no such Prior Work Product. Employee represents and warrants that the inclusion of any Prior Work Product on
Appendix A of this Agreement will not affect Employee's ability to perform all obligations under this Agreement.

**C.** **Company Rights.** 

1. All right, title and interest in any Company Work Product is the exclusive property of the Company and/or its
affiliates, and Employee shall use such Company Work Product only for the benefit of the Company and/or its affiliates. Employee hereby acknowledges and agrees that to the fullest extent permitted by law, all Company Work Product shall be deemed to
be "Work Made for Hire" (as that term is defined in the U.S. Copyright Act), and all rights thereto shall be owned solely and exclusively by the Company in perpetuity. In the event that any portion or aspect of any Company Work Product
otherwise does not qualify for or is deemed not to be Work Made for Hire, Employee hereby irrevocably transfers and assigns to Company, without any further compensation, all of Employee's right, title and interest, throughout the world, in and
to such Company Work Product, including without limitation, all Intellectual Property Rights, and hereby waives any so-called "moral rights" with respect to such Company Work Product. At the
request of the Company, Employee will execute any documents and take any actions that may be needed to effect and confirm such transfer and assignment and waiver.

------

2. If, in the course of Employee's employment with the Company, Employee incorporates into or uses in
connection with any Company Work Product any Prior Work Product, Employee hereby grants to the Company a nonexclusive, royalty-free, fully paid-up, irrevocable, perpetual, worldwide license, with the right to
grant and authorize sublicenses, to make, have made, modify, use, import, offer for sale, and sell such Prior Work Product as part of or in connection with such product, process, service, technology or other work and to practice any method related
thereto.

3. Employee agrees promptly to disclose to the Company, or any designee, all Company Work Product which are or may
be subject to the provisions of this Section C.

**D.** **Maintenance of Records**. Employee agrees to keep and maintain adequate, current, accurate, and authentic
written records of all Work Product made by Employee (solely or jointly with others) during the term of Employee's employment with the Company. The records will be in the form of notes, sketches, drawings, electronic files, reports, or any
other format that may be specified by the Company. The records are and will be available to and remain the sole property of the Company at all times.

**E.** **Obtaining and Enforcing Proprietary Rights**. Employee agrees to assist the Company, or its designee, at
the Company's expense, in every proper way to secure the rights of the Company and/or its affiliates in the Company Work Product and any rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent
information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments which the Company shall deem proper or necessary in order to apply for, register, obtain, maintain, defend,
and enforce such rights and in order to assign and convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Company Work Product and any rights relating thereto, and testifying in
a suit or other proceeding relating to such Company Work Product and any rights relating thereto. Employee further agrees that Employee's obligation to execute or cause to be executed, when it is in Employee's power to do so, any such
instrument or papers shall continue after the termination of this Agreement. If the Company is unable because of Employee's mental or physical incapacity or for any other reason to secure Employee's signature with respect to any Work
Product including, without limitation, to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering such Work Product, then Employee hereby irrevocably designates and appoints the Company and
its duly authorized officers and agents as Employee's agents and attorneys in fact, whose power is coupled with an interest, to act for and in Employee's behalf and stead to execute and file any papers, oaths and to do all other lawfully
permitted acts with respect to such Company Work Product with the same legal force and effect as if executed or done by Employee.

------

**IV. <u>GENERAL PROVISIONS</u>** 

**A.** **Actions.** 

1. <u>Governing Law</u>. This Agreement shall be governed by and construed in accordance with the laws of the
State of New York, both as to interpretation and performance, but without regard to the conflicts of law provisions thereof.

2. <u>Jurisdiction and Venue</u>. The Company and Employee acknowledge and agree to the exclusive jurisdiction of,
and venue in, the State and federal courts, sitting in the State of New York, for any action arising out of or related to the interpretation and/or enforcement of this Agreement. Neither party shall object to nor seek to change, venue or
jurisdiction in any action filed or pursued in accordance with the foregoing.

3. <u>Remedies</u>.

(a) <u>Accounting for Profits</u>. Employee covenants and agrees that in the event Employee violates any of
Employee's restrictions or obligations under this Agreement, the Company shall be entitled, to the greatest extent permitted by law, to an accounting and repayment of all profits, compensation, commissions, remuneration and other benefits
which Employee directly or indirectly receives and/or is entitled to receive, as a result of, or growing out of, the violation of any restrictions or obligation under this Agreement. Employee and the Company acknowledge and agree that such remedy
shall be in addition to and not in limitation of any injunctive relief, damages, and any other rights or remedies to which the Company is or may be entitled at law, in equity or under this Agreement.

(b) <u>Entitlement to Equitable Relief.</u> The Company and Employee acknowledge and agree that the breach by
Employee of any restriction or obligation under this Agreement will cause the Company substantial, immediate and irreparable harm, and that the full extent of damages caused by any violation of this Agreement would be impossible to ascertain, and
that there is no adequate remedy at law in the event of such breach. Accordingly, the Company and Employee hereby agree that the Company shall be entitled to injunctive relief, without posting bond, by bringing an appropriate action for such remedy,
and that this remedy is without prejudice to the other rights the Company has, in law or equity or under this Agreement, including, without limitation, its claim for damages for the breach of this Agreement. In connection with any application for
injunctive relief hereunder, to the greatest extent permitted by law, any alleged offset or counterclaim that the Employee may claim or assert, shall not be a basis to deny injunctive relief to Company, but may be addressed in the underlying
action.

**B.** **Non-Waiver**. No failure to exercise, delay in exercising or
single or partial exercise of any right, power or remedy by either party under this Agreement shall constitute a waiver thereof or shall preclude any other or further exercise of the same or any other right, power or remedy.

------

**C.** **Applicability**. Any change or changes in Employee's title, duties, responsibilities, employment
status, salary and/or compensation, shall not affect the validity or scope of this Agreement, and the provisions of this Agreement, including those of Sections I, II, III, and IV, will, to the greatest extent permitted by law, remain in full force
and effect, regardless of such change or changes, and regardless of which Party caused or instigated such change or changes.

**D.** **No Modification of At-Will Employment.** Employee is an at-will employee of the Company. Nothing in this Agreement shall be construed: (i) to give to Employee any right to employment for a specific period of time; or (ii) to limit or restrict Employer's
and Employee's rights to terminate such employment with the Company, or (iii) to otherwise alter or modify the at-will nature of Employee's employment with the Company.

**E.** **Fees.** To the greatest extent permitted by law, Employee shall pay the Company's reasonable
attorneys' fees and costs incurred in seeking to enforce this Agreement.

**F.** **Severability.** This Agreement is severable. If one or more of the provisions of this Agreement are deemed
void by law, then the remaining provisions shall continue in full force and effect. The parties agree that a court considering this Agreement may modify any unenforceable term hereof to render this Agreement lawful and enforceable, and to
effectuate, to the fullest extent permitted by law, the Parties' intent as set forth herein. Further, this provision shall be construed and interpreted in a manner consistent with Section I(F) of this Agreement.

**G.** **Successors and Assigns.** This Agreement may not be assigned by Employee without the Company's prior
written consent, and any such attempted assignment shall be void. The Company may, without the consent of Employee, and in its sole discretion, assign this Agreement to another entity, or to a successor or affiliate, or as part of a transfer or sale
of all or a portion of Company assets. The rights and covenants of this Agreement shall inure and extend to the Parties hereto, their respective heirs, personal representatives, successors and permitted assigns.

**H.** **Survival.** The Parties acknowledge that the provisions of this Agreement require that Employee comply
with restrictions and other provision(s) hereunder, after the end of Employee's employment with the Company. Employee agrees to comply with such restrictions and other provisions, regardless of whether his employment has terminated, and
regardless of which party instigated or caused such termination.

**I.** **Counterparts.** This Agreement may be executed in counterparts. All counterparts taken together shall
constitute a single Agreement. A facsimile/photocopied signature shall have the same force and effect of an original signature.

**J.** **Entire Agreement.** Except as otherwise specifically provided herein, this Agreement sets forth the entire
agreement and understanding between the Company and Employee relating to the matter set forth herein, and supersedes all prior understandings, negotiations and representations with respect to this Agreement and with respect to entering into this
Agreement. Notwithstanding the foregoing and any other provisions hereof, this Agreement shall not supersede or in any way nullify or change any obligation that Employee has to protect the Company's confidential information, or to refrain from
competing with the Company, and/or from soliciting Company employees, vendors or customers, during or after Employee's employment is terminated, and/or to assign intellectual property to the Company, which

------

obligations are: (i) imposed by law or equity; or (ii) which are imposed by contract or other agreement that Employee has previously entered into or is entering into at this time, but rather, such obligations shall remain in full force and effect and are cumulative of the remedies set forth herein. No modification of or amendment to this Agreement, or any waiver of any rights under this Agreement, will be effective unless in a writing signed by the parties.

IN WITNESS WHEREOF, the Company and Employee have executed this Agreement effective as of the date first set forth above.

---

| | | |
|:---|:---|:---|
| **HENRY SCHEIN, INC.** | **HENRY SCHEIN, INC.** | **ANDREA ALBERTINI** |
| By: | /s/ Lorelei McGlynn | /s/ Andrea Albertini |
| Name: | Lorelei McGlynn | Date: August 23, 2023 |
| Title: | SVP, CHRO |  |
| Date: | August 23, 2023 |  |

---

## Exhibit 21.1

**Exhibit 21.1** 

**List of Subsidiaries** 

---

| | |
|:---|:---|
| **Subsidiary** | **Jurisdiction of incorporation or organization** |
| ACE Surgical Supply Co., Inc. | Massachusetts |
| BHCL US Holdings Inc.<sup>1</sup> | Delaware |
| Camlog USA, Inc.<sup>2</sup> | Delaware |
| eAssist, Inc.<sup>3</sup> | Wyoming |
| Exan Enterprises Inc.<sup>4</sup> | Nevada |
| Handpiece Parts & Repairs, Inc.<sup>5</sup> | Delaware |
| Henry Schein (Lancaster, PA) Inc. | Pennsylvania |
| Henry Schein Europe, Inc.<sup>6</sup> | Delaware |
| Henry Schein Global Sourcing, Inc.<sup>7</sup> | Delaware |
| Henry Schein Home Health, LLC<sup>8</sup> | Delaware |
| Henry Schein International LLC | Delaware |
| Henry Schein Latin America Pacific Rim, Inc.<sup>9</sup> | Delaware |
| Henry Schein Medical Systems, Inc. | Ohio |
| Henry Schein MSO, LLC | Delaware |
| Henry Schein PPT, Inc. | Wisconsin |
| Henry Schein Practice Solutions Inc.<sup>10</sup> | Utah |
| Henry Schein Puerto Rico, Inc. | Puerto Rico |
| Henry Schein Supply, Inc. | New York |
| HS Brand Management, LLC | Delaware |
| HS Financial Holdings, Inc.<sup>11</sup> | Delaware |
| HS TM Holdings, LLC<sup>12</sup> | Delaware |
| HSFR, Inc. | Delaware |
| HSG-S Corp.<sup>13</sup> | Delaware |
| HSI Gloves, Inc. | Delaware |
| HSI RE I, LLC | Delaware |
| Insource, Inc. | Virginia |
| Modern Laboratory Services, Inc. | California |
| Ortho2, LLC | Delaware |
| Project Helium Holdings, LLC<sup>14</sup> | Delaware |
| Project Spartan Holdings Corp.<sup>15</sup> | Delaware |
| S & S Discount, Inc.<sup>16</sup> | Delaware |
| SAS Holdco, Inc.<sup>17</sup> | Delaware |
| TDSC, Inc. | Delaware |
| Toy Products Corp.<sup>18</sup> | Delaware |
| Trimed, Inc.<sup>19</sup> | California |

---

<sup>1</sup> BHCL US Holdings Inc. is the parent company of 16 consolidated, wholly-owned subsidiaries, eight which operate in the dental implant and distribution industries in the United States and eight which operate in the dental implant and distribution industries outside the United States. BHCL US Holdings Inc. is also the parent company of a consolidated, majority-owned subsidiary, BioHorizons Camlog Italia SRL, which operates in the dental implant and distribution industry outside the United States. 

<sup>2</sup> Camlog USA, Inc. is the parent company of three consolidated, wholly-owned subsidiaries which provide services to healthcare practices in the United States. Camlog USA, Inc. is also the parent company of the following three consolidated, majority-owned subsidiaries, which provide services to healthcare practitioners in the United States: Henry Schein Financial Services, LLC; Large Practice Sales, LLC; and Invisible DSO Advisor, LLC. 

<sup>3</sup> eAssist, Inc. is the parent company of the following four consolidated, majority-owned subsidiaries, all which operate to provide consulting and educational services in the dental industry in the United States: eAssist Consulting, LLC; eAssist Publishing, LLC; eAssist University, LLC; and Unitas PPO Solutions, LLC. 

<sup>4</sup> Exan Enterprises Inc. is the parent company of one consolidated, wholly-owned subsidiary which operates in the dental management software industry in the United States.

<sup>5</sup> Handpiece Parts & Repair, Inc. is the parent company of two consolidated, wholly-owned subsidiaries which operate in the dental handpiece and repair industry in the United States.

------

<sup>6</sup> Henry Schein Europe, Inc. is the parent company of 79 consolidated, wholly-owned subsidiaries, six which operate in the health care distribution industry in the United States and 73 which operate in the health care distribution industry outside the United States. Henry Schein Europe, Inc. is also the parent company of the following 22 consolidated, majority-owned subsidiaries, all which operate in the health care distribution industry outside the United States: AS Medizintechnik Verwaltungs GmbH; Biotech Dental Academy S.A.S.; Biotech Dental Digital S.A.S.; Biotech Dental Manufacturing S.A.; Biotech Dental Smilers S.A.S.; Biotech Dental S.A.S.; Dental 2R S.A.S.; Henry Schein Dental Warehouse (Pty) Ltd.; Infomed Servicios Informáticos, S.L.; innOralis, S.A.S.; Kabushiki Kaisha BA International; Label Dent Bordeaux S.A.S.; Label Dent Group S.A.S.; Label Dent La Roseraie S.A.S.; Laboratoire Label Dent Anglet S.A.S.; Laboratoire Philip S.A.S.; Laboratoire Premier Bordeaux S.A.S.; Medentis Medical GmbH; Newshelf 1223 Proprietary Limited; Opti health consulting GmbH; TP Connect S.A.S.; and Ztech Digital and Esthetics, S.L. 

<sup>7</sup> Henry Schein Global Sourcing, Inc. is the parent company of one consolidated, wholly-owned subsidiary which provides health care regulatory and operational services outside of the United States.

<sup>8</sup> Henry Schein Home Health, LLC is the parent company of three consolidated, wholly-owned subsidiaries which operate in the health care industry in the United States. Henry Schein Home Health, LLC is also the parent company of the following six consolidated, majority-owned subsidiaries, all of which operate in the health care industry in the United States: AEP Mini Holdco, LLC; Dharma Ventures Group, Inc.; Lorraine Surgical Supply Company, Inc.; Shield-California Health Care Center, Inc., Shield-Denver Health Care Center, Inc., and Shield-Texas Healthcare, Inc. 

<sup>9</sup> Henry Schein Latin America Pacific Rim, Inc. is the parent, holding company of 11 consolidated, wholly-owned subsidiaries, three which operate in the health care distribution industry in the United States and eight which operate in the health care distribution industry outside of the United States. Henry Schein Latin America Pacific Rim, Inc. is also the parent company of the following 27 consolidated, majority-owned subsidiaries, all which operate in the health care distribution industry outside the United States: Accord Corporation Limited; Adaam Pty Ltd.; Adaam Unit Trust; Alta-Dent Corporation; BA Pro Repair Ltd.; Beijing Ruisimei Henry Schein Medical Instrument Co., Ltd.; CB Healthcare Consulting Pty Ltd.; De Healthcare Limited; Hangzhou Lixue Henry Schein Medical Instrument Co., Ltd.; Henry Schein China Management Co. Ltd.; Henry Schein China Services Limited; Henry Schein Hemao Guangzhou Medical Device Co., Ltd.; Henry Schein Hong Kong Limited; Henry Schein Regional Limited; Henry Schein Regional Pty Ltd as the Trustee for the Henry Schein Regional Trust; Henry Schein Regional Trust; Henry Schein Shvadent (2009) Ltd.; Henry Schein Sunshine (Beijing) Medical Device Co. Ltd.; Henry Schein Trading (Shanghai) Co., Ltd.; Medi-Consumables PTY Limited; Pacific Dental Specialties Limited; Pacific Dental Specialties Pty Ltd.; Regional Health Care Group Pty Limited; Regional Technology Systems Pty Limited; Schuster Comerico De Equipamentos Odontologicos S.A.; Wuhan Hongchang Henry Schein Dental Instrument Co., Ltd.; and Zhengzhou Yifeng Henry Schein Dental Instrument Co., Ltd. 

<sup>10</sup> Henry Schein Practice Solutions Inc. is the parent company of 32 consolidated, wholly-owned subsidiaries, four which operate in the digital dental products and solutions industry in the United States and 28 which operate in the digital dental products and solutions industry outside the United States. Henry Schein Practice Solutions Inc. is also the parent company of Henry Schein One, LLC and Lighthouse 360, Inc., consolidated, majority-owned subsidiaries, which operate in the digital dental products and solutions industry within and outside of the United States. Additionally, Henry Schein Practice Solutions Inc. is the parent company of the following 14 consolidated, majority-owned subsidiaries, all which operate in the digital dental products and solutions industry outside the United States: Axium Solutions ULC; LSI S.A.; Henry Schein One Italia S.r.l.; Henry Schein One Australia; Henry Schein One New Zealand; Infomed Software, S.L.; HS1 Holdings I, LLC; HSLC Participações S.A.; SAS; Henry Schein One Austria GmbH; Henry Schein One UK Limited; Orisline Portugal Unipessoal Lda; Quantity Serviços e Comércio de Produtos para a Saúde S.A.; and Real Cloud Imaging, Inc. 

<sup>11</sup> HS Financial Holdings, Inc. is the parent company of six consolidated, wholly-owned subsidiaries, five which oversee intercompany financing in the United States and one which operates outside the United States and acts as the beneficiary of a trust.

<sup>12</sup> HS TM Holdings, LLC is the parent, holding company of one consolidated, wholly-owned subsidiary which holds and manages trademarks within and outside the United States.

<sup>13</sup> HSG-S Corp. is the parent, holding company of nine consolidated, wholly-owned subsidiaries, seven which operate in the health care distribution industry in the United States, and two which operate in the health care distribution industry outside of the United States.

<sup>14</sup> Project Helium Holdings, LLC is the parent, holding company of one consolidated, wholly-owned subsidiary which operates in the dental handpiece repair and sales industry in the United States.

<sup>15</sup> Project Spartan Holdings Corp. is the parent, holding company of eight consolidated, wholly-owned subsidiaries which operate in the health care industry in the United States.

------

<sup>16</sup> S&S Discount Supply, Inc. is the parent, holding company of the following two consolidated, majority-owned subsidiaries, both which operate in the dental manufacturing and/or distribution industry in the United States: Ortho Organizers Holdings, Inc. and Ortho Organizers, Inc.

<sup>17</sup> SAS Holdco, Inc. is the parent company of two wholly-owned subsidiaries which operate in the direct-to-consumer medical consumables in the industry in the United States.

<sup>18</sup> Toy Products Corp. is the parent, holding company of Sherman Specialty LLC, a consolidated, majority-owned subsidiary which distributes toys to dental and medical offices in the United States.

<sup>19</sup> Trimed, Inc. is the parent company of ten consolidated, majority-owned subsidiaries, all of which operate in the orthopedic fixation industry within and outside the United States: Adessy S.A, Implantes TriMed Mexico; S. DE R.L. DE C.V.; TriMed Brasil Importação e Distribuição LTDA; TriMed Chile SpA; TriMed Implantes S.A.; TriMed Japan Kabushiki Gaisha (K.K.); TriMed Latin America, LLC; TriMed Ortho International Limited; TriMed Peru SAC; and TriMed Uruguay S.A.

## Exhibit 23.1

**Exhibit 23.1** 

<u>Consent of Independent Registered Public Accounting Firm</u> 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-283783, 333-283782, 333-253633, 333-212994, 333-192788, 333-171400, 333-164360, 333-111914, 333-91778, 333-35144, 333-39893, 333-33193, and 333-05453) of Henry Schein, Inc. (the Company) of our reports dated February 24, 2026, relating to the consolidated financial statements and the effectiveness of the Company's internal control over financial reporting, which appear in this Annual Report on Form 10-K.

/s/ BDO USA, P.C.

New York, NY

February 24, 2026

## Exhibit 31.1

**Exhibit 31.1** 

**CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE SECURITIES** 

**EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE** 

**SARBANES-OXLEY ACT OF 2002** 

I, Stanley M. Bergman, certify that:

1. I have reviewed this annual report on Form 10-K of Henry Schein, Inc. (the "registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Dated: February 24, 2026 | /s/ Stanley M. Bergman<br> Stanley M. Bergman<br> Chairman and Chief Executive Officer |

---

## Exhibit 31.2

**Exhibit 31.2** 

**CERTIFICATION PURSUANT TO RULE 13a-14(a) OR 15d-14(a) OF THE SECURITIES** 

**EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE** 

**SARBANES-OXLEY ACT OF 2002** 

I, Ronald N. South, certify that:

1. I have reviewed this annual report on Form 10-K of Henry Schein, Inc. (the "registrant");

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Dated: February 24, 2026 | /s/ Ronald N. South<br> Ronald N. South<br> Senior Vice President and<br> Chief Financial Officer |

---

## Exhibit 32.1

**Exhibit 32.1** 

**CERTIFICATION PURSUANT TO** 

**18 U.S.C. SECTION 1350,** 

**AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the annual report on Form 10-K of Henry Schein, Inc. (the "Company") for the period ended December 27, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Stanley M. Bergman, the Chairman and Chief Executive Officer of the Company, and I, Ronald N. South, Senior Vice President and Chief Financial Officer of the Company, do hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
| Dated: February 24, 2026 | /s/ Stanley M. Bergman |
|  | Stanley M. Bergman<br> Chairman and Chief Executive Officer |
| Dated: February 24, 2026 | /s/ Ronald N. South |
|  | Ronald N. South<br> Senior Vice President and<br> Chief Financial Officer |

---

This certification accompanies each Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

## Exhibit 99.5

**Exhibit 99.5** 

**AMENDMENT NUMBER ONE** 

**TO THE** 

**HENRY SCHEIN, INC.** 

**SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN** 

**AMENDED AND RESTATED EFFECTIVE AS OF SEPTEMBER 1, 2025** 

**WHEREAS**, Henry Schein, Inc. (the "<u>Company</u>") maintains the Henry Schein, Inc. Supplemental Executive Retirement Plan, amended and restated effective as of September 1, 2025, and as subsequently amended (the "<u>Plan</u>");

**WHEREAS,** pursuant to Section 16 of the Plan, the Board of Directors of the Company (the "<u>Board</u>") or an authorized committee may amend the Plan;

**WHEREAS,** pursuant to the Charter of the Compensation Committee of the Board (the "<u>Committee</u>"), the Committee is authorized to amend the Plan; and

**WHEREAS,** the Committee wishes to amend the Plan to clarify the Plan's definition of "Recognized Compensation."

**NOW, THEREFORE**, the Plan is hereby amended, effective as of November 17, 2025, as follows:

1. Section 1(gg) of the Plan is hereby amended in its entirety to read as follows:

"(gg) '**Recognized Compensation**' means the dollar limitation pursuant to Section 401(a)(17) of the Code or such higher amount specified by the Committee from time to time prior to the determination of the amount of any contribution pursuant to Section 3(a)."

\* \* \*

**IN WITNESS WHEREOF**, this amendment has been executed this 30<sup>th</sup> day of December, 2025.

---

| | |
|:---|:---|
| **HENRY SCHEIN, INC.** | **HENRY SCHEIN, INC.** |
| By: | /s/ Christine Sheehy |
| Name: | Christine Sheehy |
| Title: | Senior Vice President and Chief Human Resources Officer |

---